Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Journal: The Lancet. Oncology
Published: November 27, 2019
First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 12, 2019
Immune profiles of desmoplastic small round cell tumor and synovial sarcoma suggest different immunotherapeutic susceptibility upfront compared to relapse specimens.
Journal: Pediatric blood & cancer
Published: May 16, 2018
Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.
Journal: Oncotarget
Published: December 14, 2016
Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors.
Journal: Molecular therapy oncolytics
Published: February 22, 2016
To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses.
Journal: Viruses
Published: October 31, 2015
Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children.
Journal: Molecular therapy oncolytics
Published: October 06, 2015
Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children.
Journal: Molecular therapy oncolytics
Published: October 06, 2015
Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic Trials.
Journal: Pediatric blood & cancer
Published: August 06, 2015
Going back to class I: MHC and immunotherapies for childhood cancer.
Journal: Pediatric blood & cancer
Published: July 26, 2014
Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity.
Journal: Molecular therapy oncolytics
Published: July 07, 2014
Last Updated: 09/26/2026